OS Therapies CEO Grants 500,000 Zero‑Value Options, Signaling Bullish Outlook Amid Rising Share Price and Dilution Concerns
OS Therapies’ CEO grants 500,000 options, signaling confidence and potential upside amid rising share price, yet investors must watch clinical milestones and dilution risk.
3 minutes to read